ADVFN - Advanced Financial Network.
HOME» NYSE » B » BSX Stock Price » BSX Stock News

Boston Scientific Share News

 Boston Scientific Corp. Stock Price
BSX Stock Price
 Boston Scientific Corp. Stock Chart
BSX Stock Chart
 Boston Scientific Corp. Stock News
BSX Stock News
 Boston Scientific Corp. Company Information
BSX Company Information
 Boston Scientific Corp. Stock Trades
BSX Stock Trades

Federal Court Rules In Favor Of Boston Scientific In J&J Patent Case

DOW JONES NEWSWIRES A federal court ruled a stent system made by Boston Scientific Corp. (BSX) doesn't infringe on Johnson & Johnson (JNJ) patents, a judgment that helps the medical-device maker notch a win in a patent war with the health-care products giant. Johnson & Johnson had alleged in a 2008 suit that Boston Scientific's Promus everolimus-eluting coronary stent system infringed on two of its patents. Boston Scientific on Monday touted a decision from a federal court in New Jersey, saying the court had found the patents to be invalid. "Boston Scientific will continue to vigorously defend against any claims of infringement," said Tim Pratt, general counsel for the company. A spokeswoman for Johnson & Johnson couldn't immediately be reached for comment. The two companies have been locked in a long-running battle over intellectual property for heart stents, with both scoring some victories along the way. Johnson & Johnson shares were recently down slightly to $65.25 premarket, while Boston Scientific were up 1.2% to $6.05. -By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com

Stock News for Boston Scientific (BSX)
DateTimeHeadline
05/27/201506:59:00Boston Scientific Names Prof. John Mark Morgan as Senior Medical...
05/26/201508:30:00Boston Scientific To Participate In The Goldman Sachs 36th Annual...
05/20/201512:15:10What Is the S&P 500 Index?
05/20/201502:31:00Post-Market Study Evaluating The Boston Scientific Lotus⢠Valve S...
05/19/201516:21:25Statement of Changes in Beneficial Ownership (4)
05/19/201516:21:25Statement of Changes in Beneficial Ownership (4)
05/19/201507:52:00New Data Presented At EuroPCR 2015 Demonstrate Strong Performance...
05/15/201508:30:28Statement of Changes in Beneficial Ownership (4)
05/12/201515:08:32Current Report Filing (8-k)
05/12/201510:53:00Boston Scientific Completes $1.85 Billion Senior Notes Offering
05/11/201516:06:47Statement of Changes in Beneficial Ownership (4)
05/11/201509:24:00Boston Scientific Announces Scheduled Presentations at Heart...
05/08/201517:03:06Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)
05/08/201506:04:05Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
05/08/201506:04:04Current Report Filing (8-k)
05/07/201517:38:00Boston Scientific Prices $1.85 Billion Of Senior Notes
05/07/201516:28:32Statement of Changes in Beneficial Ownership (4)
05/07/201516:28:32Statement of Changes in Beneficial Ownership (4)
05/07/201516:28:32Statement of Changes in Beneficial Ownership (4)
05/07/201516:28:32Statement of Changes in Beneficial Ownership (4)

Boston Scientific and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad